ZYME
ZYMEWORKS (ZYME)
NASDAQ
$23.86+$0.59 (+2.56%)
Price as of Jun 23, 2026 4:10 PM EDT
  • $1.7B
    Market Cap
  • 86.53%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
6.0M
-92.14%
76.3M
+0.38%
76.0M
-81.57%
412.5M
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
6.0M
-92.14%
76.3M
+0.38%
76.0M
-81.57%
412.5M
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-137.0M
+1.77%
-134.6M
-6.27%
-143.6M
-31.15%
-208.6M
N/A
Depreciation and Amortization Expense
4.1M
-9.79%
4.5M
+66.40%
2.7M
+166.21%
1.0M
N/A
Total Operating Expenses
198.5M
-6.98%
213.4M
-0.30%
214.1M
-24.08%
282.0M
N/A
Operating Profit
-92.5M
-32.50%
-137.1M
-0.68%
-138.1M
-205.77%
130.5M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
-559,000
-200.18%
558,000
+162.42%
-894,000
-180.54%
1.1M
N/A
Income before Taxes
-79.8M
-31.61%
-116.6M
-2.21%
-119.2M
-188.17%
135.2M
N/A
Income Taxes
1.4M
-77.38%
6.1M
+1,171.13%
-568,000
-105.21%
10.9M
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-81.1M
-33.88%
-122.7M
+3.39%
-118.7M
-195.44%
124.3M
N/A
Net Income from Continuing Operations Applicable to Common
-79.8M
-31.61%
-116.6M
-2.21%
-119.2M
-188.17%
135.2M
N/A
Basic EPS and Net Income
-1.08
-33.33%
-1.62
-5.81%
-1.72
-190.05%
1.91
N/A
Diluted EPS and Net Income
-1.08
-33.33%
-1.62
-5.81%
-1.72
-190.53%
1.90
N/A
Basic Weighted Average Shares
75.4M
-0.58%
75.8M
+10.14%
68.9M
+5.63%
65.2M
N/A
Diluted Weighted Average Shares
75.4M
-0.61%
75.9M
+10.19%
68.9M
+5.54%
65.2M
N/A
Balance Sheet
Cash and Cash Equivalents
41.2M
-37.74%
66.1M
-58.05%
157.6M
-60.70%
400.9M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
216.8M
+137.37%
91.3M
N/A
Cash and Cash Equivalents and Short-Term Investments
41.2M
-37.74%
66.1M
-82.34%
374.3M
-23.95%
492.2M
N/A
Total Current Assets
248.8M
-17.20%
300.5M
-27.24%
412.9M
-24.19%
544.7M
N/A
Accumulated Depreciation
20.9M
+17.08%
17.8M
-13.68%
20.7M
+55.32%
13.3M
N/A
Property and Plant and Equipment and Net
15.5M
-12.17%
17.6M
-11.07%
19.8M
-19.69%
24.7M
N/A
Total Long-Term Assets
15.5M
-12.17%
17.6M
-11.07%
19.8M
-19.69%
24.7M
N/A
Total Assets
346.5M
-25.17%
463.1M
-20.28%
580.9M
-10.46%
648.7M
N/A
Income Taxes Payable
6.1M
+24.99%
4.9M
-4.34%
5.1M
+94.48%
2.6M
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
42.3M
-52.07%
88.3M
+58.34%
55.8M
-41.69%
95.6M
N/A
Total Long-Term Debt
481.3M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
278,000
-69.88%
923,000
-45.74%
1.7M
-45.15%
3.1M
N/A
Total Liabilities
78.0M
-37.24%
124.3M
+7.11%
116.1M
-25.48%
155.8M
N/A
Retained Earnings
-953.2M
+14.79%
-830.3M
+22.57%
-677.4M
+21.24%
-558.8M
N/A
Total Stockholders Equity
268.5M
-20.74%
338.8M
-27.12%
464.8M
-5.71%
493.0M
N/A
Total Shares Outstanding
74.6M
+8.23%
69.0M
-1.64%
70.1M
+11.19%
63.1M
N/A
Cash Flow
Cash from Operating Activities
-33.0M
-70.01%
-110.0M
-6.98%
-118.3M
-182.09%
144.1M
N/A
Capital Expenditures
1.5M
-23.61%
2.0M
-19.52%
2.5M
-69.64%
8.2M
N/A
Cash from Investing Activities
26.7M
-31.20%
38.8M
+118.70%
-207.3M
+284.88%
-53.8M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-18.6M
-9.26%
-20.5M
-124.99%
81.8M
-24.62%
108.6M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-1,542.48%
+758.42%
-179.69%
-1.06%
-181.62%
N/A
N/A
N/A
Return on Assets
-20.04%
-14.74%
-23.51%
+21.77%
-19.30%
N/A
N/A
N/A
Return on Equity
-26.72%
-12.50%
-30.54%
+23.23%
-24.78%
N/A
N/A
N/A
Revenue Growth
-92.14%
-24,087.69%
0.38%
+100.47%
-81.57%
N/A
N/A
N/A
Current Ratio
5.88
+72.75%
3.40
-54.05%
7.41
N/A
N/A
N/A
Cash Ratio
0.97
+29.91%
0.75
-73.50%
2.83
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow